BCM
PSTX

Boxer Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Boxer Capital Management’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,000,000
Closed -$19.2M – 62
2024
Q4 		$19.2M Buy
+2,000,000
New +$10.4M 1.63% 19

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boxer Capital Management's PSTX Position: Q1 2025 in Review

Boxer Capital Management sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 2,000,000 shares — an estimated $19.2M sold.

Boxer Capital Management first reported a position in PSTX in Q4 2024 and held it in 1 quarter. The position peaked at $19.2M in Q4 2024. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Boxer Capital Management reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Boxer Capital Management sold 2,000,000 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $19.2M.
  • Boxer Capital Management first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Boxer Capital Management's Poseida Therapeutics, Inc. Common Stock position peaked at $19.2M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Boxer Capital Management's 13F filing for Q1 2025, filed 15 May 2025.